Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Motor Activity 2Ovarian Neoplasms 1Neoplasms 1

Interventions

Cyclophosphamide 548pembrolizumab 382Radiotherapy 363Bevacizumab 359Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Has results × Fitness Trackers × Clear all
NCT03364673 2023-10-13

Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer

Dana-Farber Cancer Institute

Phase NA Completed
29 enrolled 16 charts
Gynecologic

Motor Activity, Ovarian Neoplasms

NCT01778127 2015-05-21

A Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer

St. Jude Children's Research Hospital

Phase NA Completed
105 enrolled 33 charts

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡